Cannabis for tic control: a systematic review and meta-analysis of its efficacy in Tourette syndrome management

CONCLUSION: CBMs show promising potential in reducing tics and premonitory urges in TS. Larger, placebo-controlled trials are needed to confirm efficacy, ensure safety, and optimize dosing.

via https://pubmed.ncbi.nlm.nih.gov/42229830/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1HYeX0emtvYgH07Wkz0a8n9otrdMd-JIklc_uo0I5vh1u9WMEy&fc=None&ff=20260604010809&v=2.20.0

Post a Comment